» Articles » PMID: 7723667

Compartmental Modeling of Glucagon Kinetics in the Conscious Dog

Overview
Journal Metabolism
Specialty Endocrinology
Date 1995 Apr 1
PMID 7723667
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to examine glucagon metabolism and distribution using both compartmental-modeling approaches and steady-state organ-balance techniques in conscious, overnight-fasted dogs. Arterial plasma glucose concentrations were clamped at 14 mmol/L with a variable exogenous glucose infusion. Somatostatin was infused to block endogenous secretion of insulin and glucagon. Insulin was replaced intraportally at 2.4 pmol.kg-1.min-1 to maintain basal insulin concentrations in the range from 70 +/- 4 to 95 +/- 12 pmol/L. Glucagon was not given during the control period, but was subsequently infused peripherally in four 1-hour steps of 1.0, 3.0, 6.0, and 3.0 ng.kg-1.min-1. Glucagon levels increased from 0 to 68 +/- 6, 195 +/- 19, 378 +/- 47, and 181 +/- 20 ng/mL. Compartmental analysis of glucagon concentrations showed that glucagon was distributed in one compartment with a volume approximately equal to the plasma volume. The metabolic clearance rate of glucagon was 17.6 mL.kg-1.min-1. The liver cleared 24% of glucagon, and the kidneys, 17%.

Citing Articles

Duration of morning hyperinsulinemia determines hepatic glucose uptake and glycogen storage later in the day.

Waterman H, Moore M, Smith M, Farmer B, Scott M, Edgerton D Am J Physiol Endocrinol Metab. 2024; 327(5):E655-E667.

PMID: 39259163 PMC: 11559653. DOI: 10.1152/ajpendo.00170.2024.


Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis.

Grondahl M, Lange A, Suppli M, Bagger J, Thing M, Gluud L Diabetes. 2024; 73(10):1641-1647.

PMID: 39052774 PMC: 11417434. DOI: 10.2337/db24-0305.


Duration of Morning Hyperinsulinemia Determines Hepatic Glucose Uptake and Glycogen Storage Later in the Day.

Waterman H, Moore M, Smith M, Farmer B, Scott M, Edgerton D bioRxiv. 2024; .

PMID: 38798653 PMC: 11118521. DOI: 10.1101/2024.05.10.593551.


A physiologic increase in brain glucagon action alters the hepatic gluconeogenic/glycogenolytic ratio but not glucagon's overall effect on glucose production.

Edgerton D, Kraft G, Smith M, Farmer B, Williams P, Cherrington A Am J Physiol Endocrinol Metab. 2023; 324(2):E199-E208.

PMID: 36652399 PMC: 9925168. DOI: 10.1152/ajpendo.00304.2022.


CN: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans.

Renuse S, Benson L, Vanderboom P, Ruchi F, Yadav Y, Johnson K Clin Proteomics. 2022; 19(1):16.

PMID: 35590248 PMC: 9118570. DOI: 10.1186/s12014-022-09344-2.